171 related articles for article (PubMed ID: 15390014)
1. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.
Sommer U; Hummel T; Cormann K; Mueller A; Frasnelli J; Kropp J; Reichmann H
Mov Disord; 2004 Oct; 19(10):1196-202. PubMed ID: 15390014
[TBL] [Abstract][Full Text] [Related]
2. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
[TBL] [Abstract][Full Text] [Related]
3. [Presymptomatic detection of Parkinson's disease].
Berendse HW; Booij J; Stoffers D; Ponsen MM; Hijman R; Wolters ECh
Tijdschr Gerontol Geriatr; 2002 Apr; 33(2):70-7. PubMed ID: 12012945
[TBL] [Abstract][Full Text] [Related]
4. Preclinical (premotor) Parkinson's disease.
Wolters EC; Francot C; Bergmans P; Winogrodzka A; Booij J; Berendse HW; Stoof JC
J Neurol; 2000 Apr; 247 Suppl 2():II103-9. PubMed ID: 10991655
[TBL] [Abstract][Full Text] [Related]
5. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.
Spiegel J; Hellwig D; Möllers MO; Behnke S; Jost W; Fassbender K; Samnick S; Dillmann U; Becker G; Kirsch CM
Brain; 2006 May; 129(Pt 5):1188-93. PubMed ID: 16513685
[TBL] [Abstract][Full Text] [Related]
6. No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.
Lobsien E; Schreiner S; Plotkin M; Kupsch A; Schreiber SJ; Doepp F
Mov Disord; 2012 Mar; 27(3):450-3. PubMed ID: 22237792
[TBL] [Abstract][Full Text] [Related]
7. Predicting Parkinson's disease - why, when, and how?
Postuma RB; Montplaisir J
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S105-9. PubMed ID: 20082967
[TBL] [Abstract][Full Text] [Related]
8. Olfactory dysfunction in Parkinson's disease.
Kranick SM; Duda JE
Neurosignals; 2008; 16(1):35-40. PubMed ID: 18097158
[TBL] [Abstract][Full Text] [Related]
9. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
Izawa MO; Miwa H; Kajimoto Y; Kondo T
Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
[TBL] [Abstract][Full Text] [Related]
10. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
[TBL] [Abstract][Full Text] [Related]
11. Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT.
Unger MM; Möller JC; Stiasny-Kolster K; Mankel K; Berg D; Walter U; Hoeffken H; Mayer G; Oertel WH
Mov Disord; 2008 Mar; 23(4):596-9. PubMed ID: 18175346
[TBL] [Abstract][Full Text] [Related]
12. Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder.
Fantini ML; Postuma RB; Montplaisir J; Ferini-Strambi L
Brain Res Bull; 2006 Oct; 70(4-6):386-90. PubMed ID: 17027774
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic hyposmia as a preclinical sign of Parkinson's disease.
Ponsen MM; Stoffers D; Booij J; van Eck-Smit BL; Wolters ECh; Berendse HW
Ann Neurol; 2004 Aug; 56(2):173-81. PubMed ID: 15293269
[TBL] [Abstract][Full Text] [Related]
14. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT.
Stokkel MP; Dibbets-Schneider P; Koestering E; Dragoiescu C; Blokland KA
J Nucl Med Technol; 2007 Mar; 35(1):21-6. PubMed ID: 17337653
[TBL] [Abstract][Full Text] [Related]
16. Olfactory dysfunction as a diagnostic marker for Parkinson's disease.
Haehner A; Hummel T; Reichmann H
Expert Rev Neurother; 2009 Dec; 9(12):1773-9. PubMed ID: 19951136
[TBL] [Abstract][Full Text] [Related]
17. Olfaction and apathy in Parkinson's disease.
Cramer CK; Friedman JH; Amick MM
Parkinsonism Relat Disord; 2010 Feb; 16(2):124-6. PubMed ID: 19783195
[TBL] [Abstract][Full Text] [Related]
18. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.
Bártová P; Kraft O; Bernátek J; Havel M; Ressner P; Langová K; Herzig R; Skoloudík D
Ultrasound Med Biol; 2014 Oct; 40(10):2365-71. PubMed ID: 25194454
[TBL] [Abstract][Full Text] [Related]
19. Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease.
Kim JY; Lee WY; Chung EJ; Dhong HJ
Mov Disord; 2007 Aug; 22(11):1563-6. PubMed ID: 17534948
[TBL] [Abstract][Full Text] [Related]
20. Phantosmias and Parkinson disease.
Landis BN; Burkhard PR
Arch Neurol; 2008 Sep; 65(9):1237-9. PubMed ID: 18779429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
